Jun 09, 2020
FACIT recognized with 2020 Venture Capital Regional Impact Award by the Canadian Venture Capital & Private Equity Association (CVCA)
Mar 22, 2017
FACIT Announces Investment in Propellon Therapeutics
Jun 23, 2016
Propellon Therapeutics to Accelerate WDR5 Inhibitor Development for Cancers
Receive the latest news, event invites, funding opportunities and more from the Ontario Institute for Cancer Research.